Vansteenkiste JF, Zielinski, M, Dahabreh IJ, et al.: Association of gene expression signature and clinical efficacy of MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) as adjuvant therapy in resected stage IB/II non-small cell lung cancer (NSCLC). The gene discussed is MAGEA3; the disease is non-small cell lung carcinoma.